Long-term outcomes and prognostic factors of patients with lung metastases from differentiated thyroid cancer after radioiodine therapy in Japan.
Differentiated thyroid cancer
Lung metastasis
Overall survival
Prognostic factor
Radioiodine therapy
Journal
Endocrine journal
ISSN: 1348-4540
Titre abrégé: Endocr J
Pays: Japan
ID NLM: 9313485
Informations de publication
Date de publication:
28 Mar 2023
28 Mar 2023
Historique:
medline:
31
3
2023
pubmed:
26
12
2022
entrez:
25
12
2022
Statut:
ppublish
Résumé
Long-term survival in patients with differentiated thyroid cancer (DTC) and lung metastasis remains unexplored in Japan. This study aimed to investigate the long-term survival and prognostic factors of radioiodine therapy (RIT) in a University Hospital setting. This retrospective study included 62 patients with lung metastases from DTC who received RIT between March 2005 and December 2016. According to the
Identifiants
pubmed: 36567077
doi: 10.1507/endocrj.EJ22-0463
doi:
Substances chimiques
Thyroglobulin
9010-34-8
Iodine Radioisotopes
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM